FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 322:653-659 March 8, 1990 Number 10 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

Because glucose-stimulated insulin secretion is selectively impaired during the development of insulin-dependent diabetes mellitus (IDDM), we tested the possibility that the glucose transporter of pancreatic islet beta cells is a target of the autoimmune process in patients with IDDM. We measured the uptake of 3-O-methyl-beta-D-glucose by dispersed islet cells from rats after a 15-minute incubation with purified IgG from 27 patients with newly diagnosed IDDM, 28 normal subjects, and 5 patients with non-insulin-dependent diabetes mellitus (NIDDM). The IgG fractions from 26 of the 27 patients with IDDM (96 percent), but from none of the 5 patients with NIDDM, reduced the initial rates of 3-O-methyl-beta-D-glucose uptake to at least 1 SD below the mean of the rates observed in the presence of IgG fractions from normal subjects (P less than 0.001). In contrast, the uptake of L-leucine by islet cells was not affected by any of the IgG fractions. The inhibitory activity of IgG from the patients with IDDM was abolished by preincubation with islet cells and membranes from hepatocytes, which contain the same glucose transporter as beta cells, but not with erythrocytes, which do not contain this transporter. We conclude that IgG from patients with IDDM of recent onset, but not from those with NIDDM, inhibits glucose uptake by rat islet cells. The results are consistent with the presence of an antibody against a protein involved in glucose transport by beta cells that would thereby impair glucose-stimulated insulin secretion.

Source Information

Center for Diabetes Research, Gifford Laboratories, University of Texas Southwestern Medical Center, Dallas 75235.

This article has been cited by other articles:

• Schisler, J. C., Jensen, P. B., Taylor, D. G., Becker, T. C., Knop, F. K., Takekawa, S., German, M., Weir, G. C., Lu, D., Mirmira, R. G., Newgard, C. B. (2005). The Nkx6.1 homeodomain transcription factor suppresses glucagon expression and regulates glucose-stimulated insulin secretion in islet beta cells. Proc. Natl. Acad. Sci. USA 102: 7297-7302 [Abstract] [Full Text]  
• Bain, J. R., Schisler, J. C., Takeuchi, K., Newgard, C. B., Becker, T. C. (2004). An Adenovirus Vector for Efficient RNA Interference-Mediated Suppression of Target Genes in Insulinoma Cells and Pancreatic Islets of Langerhans. Diabetes 53: 2190-2194 [Abstract] [Full Text]  
• Garcia-Ocana, A., Vasavada, R. C., Cebrian, A., Reddy, V., Takane, K. K., Lopez-Talavera, J.-C., Stewart, A. F. (2001). Transgenic Overexpression of Hepatocyte Growth Factor in the {beta}-Cell Markedly Improves Islet Function and Islet Transplant Outcomes in Mice. Diabetes 50: 2752-2762 [Abstract] [Full Text]  
• Cardinal, J. W., Allan, D. J., Cameron, D. P. (1998). Differential Metabolite Accumulation May Be the Cause of Strain Differences in Sensitivity to Streptozotocin-Induced {beta} Cell Death in Inbred Mice. Endocrinology 139: 2885-2891 [Abstract] [Full Text]  
• Winter, W.E. (1996). Type I Insulin-Dependent Diabetes Mellitus: a Model for Autoimmune Polygenic Disorders. ADR 10: 81-87 [Abstract]  
• Becker, T. C., Noel, R. J., Johnson, J. H., Lynch, R. M., Hirose, H., Tokuyama, Y., Bell, G. I., Newgard, C. B. (1996). Differential Effects of Overexpressed Glucokinase and Hexokinase I in Isolated Islets. J. Biol. Chem. 271: 390-394 [Abstract] [Full Text]  
• Milburn, J. L. Jr., Hirose, H., Lee, Y. H., Nagasawa, Y., Ogawa, A., Ohneda, M., BeltrandelRio, H., Newgard, C. B., Johnson, J. H., Unger, R. H. (1995). Pancreatic beta-Cells in Obesity. J. Biol. Chem. 270: 1295-1299 [Abstract] [Full Text]  
• Atkinson, M. A., Maclaren, N. K. (1994). The Pathogenesis of Insulin-Dependent Diabetes Mellitus. NEJM 331: 1428-1436 [Full Text]  
• Herold, K. C., Rubenstein, A. H. (1992). New Directions in the Immunology of Autoimmune Diabetes. ANN INTERN MED 117: 436-438 [Abstract]  
• Unger, R. (1991). Diabetic hyperglycemia: link to impaired glucose transport in pancreatic beta cells. Science 251: 1200-1205 [Abstract]  
• Johnson, J., Ogawa, A, Chen, L, Orci, L, Newgard, C., Alam, T, Unger, R. (1990). Underexpression of beta cell high Km glucose transporters in noninsulin-dependent diabetes. Science 250: 546-549 [Abstract]